跨国药企在中国 | 第一三共、卫材、诺和诺德、锐康迪、锐珂医疗、艾伯维、赛诺菲、默沙东、罗氏等新动态

医药健闻
Jan 12

(医药健闻2026年1月12日讯)企业动态第一三共第一三共(Daiichi Sankyo)计划斥资约3000亿日元(约合19亿美元)在全球范围内建设Enhertu生产设施。该公司正在日本、美国、德国和中国设立抗体药物偶联物(ADC)生产基地。其中,在中国将拨款240亿日元(约合1.53亿美元)用于在上海新建一个生产基地,该基地将于2030年前建成。卫材卫材(中国)药业有限公司与首都医科大学宣武医院...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10